Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S388100, C530S391100, C530S391300, C530S388150, C530S388700, C435S331000

Reexamination Certificate

active

07662927

ABSTRACT:
The present invention relates to polynucleotide and polypeptide molecules for zcyto20, zcyto21, zcyto22, zycto24, and zcyto25 proteins which are most closely related to interferon-α at the amino acid sequence level. The receptor for this protein family is a class II cytokine receptor. The present invention includes methods of reducing viral infections and increasing monocyte counts. The present invention also includes antibodies to the zcyto20 polypeptides, and methods of producing the polynucleotides and polypeptides.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5856171 (1999-01-01), Korsmeyer
patent: 6143503 (2000-11-01), Baskerville et al.
patent: 6451578 (2002-09-01), Simons et al.
patent: 6927040 (2005-08-01), Sheppard et al.
patent: 7038032 (2006-05-01), Sheppard et al.
patent: 7135170 (2006-11-01), Klucher et al.
patent: 7157559 (2007-01-01), Brady et al.
patent: 7241870 (2007-07-01), Sheppard et al.
patent: 7252969 (2007-08-01), Sheppard et al.
patent: 7253261 (2007-08-01), Sheppard et al.
patent: 7351689 (2008-04-01), Doyle et al.
patent: 2007/0020227 (2007-01-01), Sheppard
patent: 2007/0041936 (2007-02-01), Brady et al.
patent: 2007/0042468 (2007-02-01), Sheppard et al.
patent: 2007/0042469 (2007-02-01), Brady et al.
patent: 2007/0042470 (2007-02-01), Brady et al.
patent: 2007/0042471 (2007-02-01), Brady et al.
patent: 2007/0048274 (2007-03-01), Brady et al.
patent: 2007/0048275 (2007-03-01), Brady et al.
patent: 2007/0048276 (2007-03-01), Brady et al.
patent: 2007/0048277 (2007-03-01), Brady et al.
patent: 2007/0048841 (2007-03-01), Sheppard et al.
patent: 2007/0048843 (2007-03-01), Brady et al.
patent: 2007/0048844 (2007-03-01), Brady et al.
patent: 2007/0053875 (2007-03-01), Brady et al.
patent: 2007/0053933 (2007-03-01), Sheppard
patent: 2007/0054374 (2007-03-01), Brady et al.
patent: 2007/0054375 (2007-03-01), Brady et al.
patent: 2007/0054376 (2007-03-01), Brady et al.
patent: 2007/0054377 (2007-03-01), Brady et al.
patent: 2007/0055051 (2007-03-01), Brady et al.
patent: 2007/0059804 (2007-03-01), Brady et al.
patent: 2007/0065406 (2007-03-01), Brady et al.
patent: 2007/0128205 (2007-06-01), Sheppard et al.
patent: 2007/0129538 (2007-06-01), Sheppard et al.
patent: 2007/0154446 (2007-07-01), Brady et al.
patent: 2007/0166282 (2007-07-01), Brady et al.
patent: 2007/0172923 (2007-07-01), Brady et al.
patent: 2007/0264684 (2007-11-01), Sheppard et al.
patent: 2008/0032334 (2008-02-01), Sheppard et al.
patent: 2008/0075693 (2008-03-01), Klucher et al.
patent: 2008/0081786 (2008-04-01), Sheppard et al.
patent: 2008/0096252 (2008-04-01), Zamost et al.
patent: 2008/0102490 (2008-05-01), Sheppard et al.
patent: 2008/0124299 (2008-05-01), Klucher et al.
patent: 2008/0132680 (2008-06-01), Sheppard et al.
patent: 2008/0167244 (2008-07-01), Doyle et al.
patent: 0 032 134 (1981-07-01), None
patent: 10-245398 (1998-09-01), None
patent: 00/55324 (2000-09-01), None
patent: 02/20569 (2002-03-01), None
patent: 02/092762 (2002-11-01), None
patent: 03/066002 (2003-08-01), None
Kotenko et al., “IFN-1s mediate antiviral protection through a distinct class II cytokine receptor complex,”Nature Immunology 4(1):69-77, 2003.
Sheppard et al., “IL-28,Il-29 and their class II cytokine receptor IL-28R,”Nature Immunology 4(1):63-68, 2003.
University Calif. Santa Cruz Genome Browser—Chromosome 19, Apr. 20, 2001.
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001210.
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001212.
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001213.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001260.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001256.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001257.
Ensembl Contig. View Sanger Institute—Apr. 19, 2001, Accession No. AC011445.
Ensembl Contig. View Sanger Institute—Apr. 18, 2001, Accession No. AC018477.
Adams et al., “3,400 expressed sequence tags identify diversity of transcripts from human brain,”Nat. Genet. 4:256-267, 1993.
GenBank Submission XP-002202436, Oct. 12, 2000.
GenBank Submission XP-002202437, Dec. 12, 1999.
Kindsvogel et al., “Novel Interferon-Like Cytokines not Recognized by the Type I Interferon Receptor,” J. Interferon Cytokine Res. 22(1):S-48, 2002.
DOE Joint Genome Institute Stanford Human Genome Center, Accession No. AC011445, 1999.
Brack et al., “Molecular analysis of the human interferon-a gene family,” Gene 15:379-394, 1981.
Burge et al., “Prediction of Complete Gene Structures in Human Genomic DNA,” J. Mol. Biol. 268:78-94, 1997.
Vilcek, “Novel interferons,” Nature Immunology 4(1):8-9, 2003.
Xie et al., Journal of Biological Chemistry, 275(40): 31335-31339, 2000.
Komatsu et al., “A rice protein library: a data-file of rice proteins separated by two-dimensional electrophoresis,” Theoretical and Applied Genetics, 86: 935-942, 1993.
Tanase et al., “Pyridoxal 5′-phosphate binding site of pig heart alanine amintransferase,” Biochemistry, 18: 3002-3007, 1979.
Lerner, RA, “Tapping the immunological repertoire to produce antibodies of predetermined specificity,” nature, 299: 592-596, 1982.
Sheppard et al., U.S. Appl. No. 11/971,624, filed Jan. 9, 2008.
Sheppard et al., U.S. Appl. No. 11/873,272, filed Oct. 16, 2007.
Brady et al., U.S. Appl. No. 12/043,885, filed Mar. 6, 2008.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4225791

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.